The impact of receptor of advanced glycation end‐products polymorphisms on prostate cancer progression and clinicopathological characteristics

The receptor for advanced glycation end products (RAGE) overexpression was suggested to be associated with prostate cancer development and poor prognosis. In this study, we focused on the correlations between the clinicopathological characteristics and susceptibility of prostate cancer and RAGE sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Ying‐Erh, Hsieh, Ming‐Ju, Wang, Shian‐Shiang, Lin, Chia‐Yen, Chen, Yen‐Yu, Ho, Yung‐Chuan, Yang, Shun‐Fa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581310/
https://www.ncbi.nlm.nih.gov/pubmed/34708514
http://dx.doi.org/10.1111/jcmm.17025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581310/
https://www.ncbi.nlm.nih.gov/pubmed/34708514
http://dx.doi.org/10.1111/jcmm.17025

Ejemplares similares